Antimicrobial resistance prevention initiative--an update: proceedings of an expert panel on resistance

Robert C Moellering1, John R Graybill, John E McGowan

  • 1Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA. rmoeller@bidmc.harvard.edu

Insights

Antimicrobial resistance is a global threat impacting bacterial, fungal, and viral infections. Key strategies to combat this include responsible antimicrobial stewardship and developing new antimicrobial agents.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Public Health

Background:

  • Antimicrobial resistance (AMR) is a significant global challenge affecting nosocomial and community-acquired infections.
  • This worldwide problem encompasses resistance in bacteria, fungi, and viruses.

Purpose of the Study:

  • To review current trends in antibiotic, antifungal, and antiviral resistance.
  • To highlight key areas of concern and strategies for combating antimicrobial resistance.

Main Methods:

  • Review of trends in antimicrobial resistance.
  • Focus on multidrug-resistant bacteria, community-acquired methicillin-resistant Staphylococcus aureus, antifungal resistance in specific fungal species, antiviral resistance in herpesviruses, and avian influenza A.
  • Evaluation of in vitro susceptibility testing for fungal infections.

Main Results:

  • Increasing resistance observed in hospital-acquired bacteria and community-acquired methicillin-resistant Staphylococcus aureus.
  • Emerging triazole and polyene resistance in non-Candida albicans and Aspergillus species.
  • Antiviral resistance in herpesviruses and concerns regarding avian influenza A.
  • Utility of in vitro susceptibility testing for fungal infections.

Conclusions:

  • Addressing antimicrobial resistance requires a multi-faceted approach.
  • Responsible antimicrobial stewardship and the development of novel antimicrobial agents are crucial.
  • Continued surveillance and research are essential to mitigate the impact of resistant pathogens.

Related Concept Videos

Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Microbiota Modulation by Antibiotics01:21

Microbiota Modulation by Antibiotics

Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...